22 results
8-K
EX-10.1
ADPT
Adaptive Biotechnologies Corp
12 Sep 22
Adaptive Biotechnologies Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million
8:45am
into the environment, including those related to hazardous substances or wastes, air emissions and discharges to waste or public systems.
“Equity Interests” means
10-K
opwcai
26 Feb 20
Annual report
4:53pm
424B4
hvy64vs8wh55jd lcu
24 Jan 20
Prospectus supplement with pricing info
4:49pm
DRS
r48kuxt
9 Jan 20
Draft registration statement
12:00am
8-K
EX-10.2
1z92l0wfe4
7 Aug 19
Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling its Footprint in Seattle’s Growing Biotech Hub
5:29pm
424B4
cyuitd3c8zkea1rllbo
27 Jun 19
Prospectus supplement with pricing info
5:24pm
S-1
cpbne
30 May 19
IPO registration
5:20pm
S-1
EX-10.18
babe9387 yqt
30 May 19
IPO registration
5:20pm
DRS/A
asko448tx3g
8 May 19
Draft registration statement (amended)
12:00am